Quarterly report [Sections 13 or 15(d)]

Commitments and Contingencies (Additional Information) (Details)

v3.25.3
Commitments and Contingencies (Additional Information) (Details) - USD ($)
 3 Months Ended 9 Months Ended
Aug. 08, 2025
Jul. 01, 2025
Apr. 18, 2022
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Loss Contingencies [Line Items]                
Right-of-use asset       $ 0   $ 0   $ 101,437
Lease Expense       35,934 $ 35,296 106,525 $ 105,887  
ShortTerm Lease Payments       6,427 $ 5,521 16,291 $ 16,827  
Prepaid Expenses and Other Current Assets [Member]                
Loss Contingencies [Line Items]                
Security deposit       $ 25,000   $ 25,000    
Lexington                
Loss Contingencies [Line Items]                
Lease Expiration Date     Sep. 30, 2025          
Lessee, Operating Lease, Discount Rate       12.00%   12.00%    
Right-of-use asset       $ 0   $ 0    
Lessor, Operating Lease, Description           The Office Lease contained escalating payments during the lease period. Upon execution of the Office Lease, the Company prepaid one month of rent, which applied to the first month's rent, and a security deposit, which is held in escrow and will be credited after the termination of the lease with a refund expected in the first half of 2026.    
Present value of operating lease liabilities       0   $ 0    
Contract Research Organization                
Loss Contingencies [Line Items]                
Clinical Research Study $ 24,800,000              
Performance milestones $ 2,500,000              
Contigent payment of performance milestones       2,500,000   2,500,000    
Estimated total remaining contract costs       19,000,000   19,000,000    
Prepaid expense           1,000,000    
Clinical Trial Supply Organization                
Loss Contingencies [Line Items]                
Clinical Trial Supply Services   $ 6,500,000            
Estimated total remaining contract costs       $ 6,300,000   $ 6,300,000